Chlorilex

CHLORILEX

Chlorpheniramine

Amarant Pharmaceuticals Private Limited

Drug Identity

Active Ingredient
Chlorpheniramine
Chemical Class
Alkylamine
Pharmacological Group
on the basis of mechanism of action
0

What is Chlorilex?

Uses
Monjuvi is used to treat diffuse large B-cell lymphoma (DLBCL ) in combination with lenalidomide that is relapsed or refractory (r/r), or...

How It Works

Chemical Class
Alkylamine
Pharmacological Group
on the basis of mechanism of action

Chlorpheniramine (Maleate) also known as Chlorphenamine Maleate. It is of Synthetic origin and belongs to Alkylamine. It belongs to H1-antagonist pharmacological group on the basis of mechanism of action. The Molecular Weight of Chlorpheniramine (Maleate) is 274.78. Its pKa is 9.2.

How to Take It

1
Adult · IV,IM,SC
10 to 20 mg — 24 hourly
Slow IV over a period of 1 minute. total dose should not exceed 40 mg.
2
Adult · PO
4 to 24 mg — 6 hourly
Max. 24 mg daily
3
Adult
Scraped Dose
Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended. chlorpheniramine is usually taken only for a short tim
4
Child · Intra Muscular
0.25 to 0.5 mg/kg — 24 hourly
5
Child · Intra Venous
0.25 to 10 mg — 24 hourly
Maximum dose= 12mg
6
Child · Oral
0.5 to 12 mg — 6 hourly
7
Child · Subcutaneous
87.5 to 0 mcg/kg — 6 hourly

Safety Alerts

Before you receive Monjuvi, tell your healthcare provider about all of your medical conditions, including if you: have an active infection or have had one recently are pregnant or plan to become pregnant are breastfeeding or plan to breastfeed

Important Warnings

Monjuvi may cause the following serious side effects: Infusion reactions
Your healthcare provider will monitor you for infusion reactions during your infusion of Monjuvi
Tell your healthcare provider right away if you get a fever, chills, rash, flushing, headache, or shortness of breath during an infusion of Monjuvi
Low blood cell counts (platelets, red blood cells, and white blood cells)
Low blood cell counts are common with Monjuvi, but can also be serious or severe
Your healthcare provider will monitor your blood counts during treatment with Monjuvi
Tell your healthcare provider right away if you get a fever of 100
4°F (38°C) or above, or any bruising or bleeding, or fever, mouth sores, skin sores, sore throat , cough, trouble breathing

Side Effects

The most common side effects of Monjuvi when given with lenalidomide in DLBCL are: respiratory tract infection feeling tired or weak diarrhea cough fever swelling of the lower legs or hands decreased appetite infusion-related reactions. The most common side effects of Monjuvi when given with lenalidomide and rituximab in FL are: respiratory tract infections diarrhea rash feeling tired or weak muscle and bone pain constipation cough infusion-related reactions.

Drug Interactions

Other drugs may interact with Monjuvi
including prescription and over-the-counter medicines
vitamins
and herbal products . Tell your healthcare provider about all the medicines you take
including prescription and over-the-counter medicines
vitamins
and herbal supplements.

Storage

Syrup Store in a well closed container, Below 40°C. Do not Freeze. Protect from Sunlight and Moisture. Tab Store in a well closed container, Below 40°C. Protect from Sunlight and Moisture.

Price Intelligence

Rs 66.86
DRAP approved maximum price · per 450ml · approved 23 Jul, 2026
No retail price observed for this pack. Retailers may not exceed the approved maximum.
Prices across sources
DRAPper 450mlRs 66.86

Should you consider an alternative?

Other options containing Chlorpheniramine, and what they are not.

For pharma professionalsCompany, market and opportunity intelligence

Company

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.